USD10
MSLE Shares
About Satellos Bioscience Inc.Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
USD10
MSLE Shares
About Satellos Bioscience Inc.Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Stats
TRADING WINDOW
Closed
OPENS AT
Jun 11 at 1:30 PM GMT+0
MARKET CAP
$122.9M
OPEN PRICE
$5.96
LOW (1Y)
$4.53
HIGH (1Y)
$13.39
LOW (24H)
$5.71
HIGH (24H)
$6.10
VOLUME (24H)
$12.36K
70.88%
Price history
Time | Price | Change |
|---|---|---|
Today | $5.96 | |
1 Day | $5.96 | |
1 Week | $6.18 | |
1 Month | $7.52 | |
1 Year | $11.25 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.